Dietger Niederwiser

43PUBLICATIONS
179CO-AUTHORS
Haematological tumoursRespiratory diseasesMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Jan 19, 2026
Treatment-free remission after two nilotinib consolidation durations in chronic myeloid leukemia treated with imatinib: Phase 3 ENESTPath results.

Delphine Rea, Slawomira Kyrcz-Krzemien, Paolo Sportoletti

|Oct 15, 2025
Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial.

Mohamad Mohty, Gerard Socié, Jeff Szer

|Jul 11, 2025
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.

Jane F Apperley, Dragana Milojkovic, Nicholas C P Cross

|May 07, 2025
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies.

Anna Sicuranza, Massimo Breccia, Francesco Iuliano

|Apr 18, 2025
Results of the Latin American Bone Marrow Transplantation Society (LABMT) activity survey 2019-2022: the impact of the COVID-19 pandemic and the increase in related haploidentical donors.

Sebastian Galeano, Carmem Bonfim, Amado Karduss

|Oct 07, 2024
Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation.

Mohamed Amine Bekadja, Dietger Niederwieser, Mohamed A Kharfan-Dabaja

Pageof 8

Frequent Collaborators

6 joint publications

Jeff Szer

4 joint publications

Richard A Larson

4 joint publications

Mohamed A Kharfan-Dabaja

4 joint publications

Mahmoud Aljurf